GNOM

Fund Description
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology.
Fund Profile
Fund Name Genomics & Biotechnology ETF
Fund Exchange Ticker GNOM
Fund Sponsor Global X
Fund ISIN US37954Y4347
Net Expense Ratio 0.68 %
Fund Inception Date 5 April 2019
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Solactive Genomics Index
Index Provider Solactive AG
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Not Applicable
Key Statistics
Return As of Date 6 August 2020
Asset Under Management 50.35 Million (USD)
1 Month Total Return -1.98 %
Year To Date Return 17.46 %
1 Year Total Return 27.35 %
3 Year Annualized Total Return
NAV 18.31
Share Outstanding 2,750,000
Top 10 Holdings (6 August 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
CRISPR THERAPEUTICS AG CRSP EQUI 0.0562800000
INVITAE CORP NVTA EQUI 0.0531500000
NATERA INC NTRA EQUI 0.0482900000
SAREPTA THERAPEUTICS INC SRPT EQUI 0.0426400000
ULTRAGENYX PHARMACEUTICAL IN RARE EQUI 0.0413500000
AGILENT TECHNOLOGIES INC A EQUI 0.0409200000
BIOMARIN PHARMACEUTICAL INC BMRN EQUI 0.0408500000
ILLUMINA INC ILMN EQUI 0.0405000000
BLUEBIRD BIO INC BLUE EQUI 0.0362600000
QIAGEN N.V. QGEN EQUI 0.0352500000